- ►ucr.ac.cr [PDF] P McGettigan, D Henry - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... JAMA. 2006;296:1633-1644. ... Cited by 368 - Related articles - BL Direct - All 9 versions
W Zhang, RW Moskowitz, G Nuki, S Abramson, … - Osteoarthritis and Cartilage, 2008 - Elsevier Sixteen experts from four medical disciplines (primary care, rheumatology,
orthopaedics and evidence-based medicine), two continents and six countries
(USA, UK, France, Netherlands, Sweden and Canada) formed the guidelines ... Cited by 133 - Related articles - All 8 versions
J Zhang, EL Ding, Y Song - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... JAMA. 2006;296:1619-1632. ... Cited by 109 - Related articles - BL Direct - All 8 versions
- ►soton.ac.uk W Zhang, RW Moskowitz, G Nuki, S Abramson, … - Osteoarthritis and Cartilage, 2007 - Elsevier Sixteen experts from four medical disciplines (primary care two, rheumatology
11, orthopaedics one and evidence-based medicine two), two continents and six
countries (USA, UK, France, Netherlands, Sweden and Canada) formed the ... Cited by 79 - Related articles - All 8 versions
S Guthikonda, EI Lev, R Patel, T DeLao, AL … - Journal of Thrombosis and Haemostasis, 2007 - interscience.wiley.com Background: The mechanisms for the variability in antiplatelet effects of
aspirin are unclear. Immature (reticulated) platelets may modulate the
antiplatelet effects of aspirin through uninhibited cyclooxygenase (COX)-1 ... Cited by 31 - Related articles - BL Direct - All 3 versions
- ►adisonline.com [PDF] SP Motsko, KL Rascati, AJ Busti, JP Wilson, … - Drug safety, 2006 - ingentaconnect.com Stephen P. Motsko,1 Karen L. Rascati,1 Anthony J. Busti,2,3 James P. Wilson,1
Jamie C. Barner,1 Kenneth A. Lawson1 and Jason Worchel4 ... 1 University of
Texas at Austin School of Pharmacy, Austin, Texas, USA 2 Texas Tech ... Cited by 25 - Related articles - BL Direct - All 9 versions
- ►onlinejacc.org IGE Zarraga, ER Schwarz - Journal of the American College of Cardiology, 2007 - Elsevier Since their approval in 1998, the popularity of selective cyclooxygenase-2
(COX2) inhibitors has swung from a domination of drug sales to serious disputes
about their cardiovascular safety. Despite the numerous studies on COX2 ... Cited by 25 - Related articles - BL Direct - All 15 versions
S Shi, U Klotz - European journal of clinical pharmacology, 2008 - Springer Abstract Selective COX-2 inhibitors (coxibs) are ap- proved for the relief of
acute pain and symptoms of chronic inflammatory conditions such as
osteoarthritis (OA) and rheumatoid arthritis (RA). They have similar ... Cited by 20 - Related articles - BL Direct - All 5 versions
PA Scott, GH Kingsley, CM Smith, EH Choy, … - British Medical Journal, 2007 - ard.bmj.com Results: 14 case-control studies (74 673 MI patients, 368 968 controls) showed
no significant association of NSAIDs with MI in a random-effects model (OR 1.17;
95% CI 0.99 to 1.37) and a small risk of MI in a fixed-effects model (OR ... Cited by 20 - Related articles - BL Direct - All 6 versions
A Strimpakos, MW Saif, KN Syrigos - Cancer and Metastasis Reviews, 2008 - Springer Abstract Pancreatic cancer is a deadly malignancy with still high mortality and
poor survival despite the significant advances in understanding, diagnosis, and
access to conventional and novel treatments. Though cytotoxic chemotherapy ... Cited by 21 - Related articles - All 4 versions
